| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 3,6 M € | -18.9% | 4,4 M € | -4.6% | 4,6 M € | -0.7% | 4,7 M € | +5.6% | 4,4 M € | -7.8% | 4,8 M € | +407.0% | 945,0 k € | |
| EBITDA | 390,1 k € | -55.1% | 868,6 k € | -8.3% | 946,7 k € | -28.0% | 1,3 M € | +23.2% | 1,1 M € | -37.8% | 1,7 M € | +462.8% | 304,9 k € | |
| Operating profit | 366,4 k € | +22.5% | 299,1 k € | +70.7% | 175,2 k € | -67.6% | 540,7 k € | +105.8% | 262,7 k € | -72.5% | 956,1 k € | +725.3% | 115,8 k € | |
| Profit/loss | 210,0 k € | +149.1% | 84,3 k € | +162.9% | 32,1 k € | -87.6% | 258,9 k € | +145.0% | 105,6 k € | -79.9% | 525,5 k € | +704.5% | 65,3 k € | |
| Equity | 1,9 M € | +12.5% | 1,7 M € | +5.3% | 1,6 M € | +2.0% | 1,6 M € | +19.8% | 1,3 M € | +8.8% | 1,2 M € | +77.5% | 677,7 k € | |
| Total assets | 5,6 M € | -21.7% | 7,2 M € | +15.6% | 6,2 M € | -17.3% | 7,5 M € | +106.3% | 3,6 M € | -37.0% | 5,8 M € | -14.9% | 6,8 M € | |
| Cash | 23,5 € | — | 22,8 € | -88.7% | 202,1 € | -100.0% | 443,7 k € | -30.8% | 640,8 k € | -29.8% | 912,6 k € | |||
| Debts | 3,5 M € | -33.4% | 5,2 M € | +22.0% | 4,2 M € | -25.2% | 5,7 M € | +165.0% | 2,1 M € | -51.3% | 4,4 M € | -24.6% | 5,8 M € | |
| Staff | 14,3 | 19,5 | 22,9 | 23,2 | 22 | 21,3 | 5,6 | |||||||
Private limited company · Westerlo · incorporated on 28/05/2018 · 14,3 ETP
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
LifeScan Belgium is a Private limited company incorporated in 2018. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Westerlo. It employs on average 14,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette